Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-B1256 |
Brand: | MCE |
CAS: | 56238-63-2 |
MDL | - |
---|---|
Molecular Weight | 446.37 |
Molecular Formula | C16H15N4NaO8S |
SMILES | O=C(C(N12)=C(COC(N)=O)CS[C@]2([H])[C@H](NC(/C(C3=CC=CO3)=N\OC)=O)C1=O)O[Na] |
Cefuroxime sodium is an orally active second-generation cephalosporin antibiotic with increased stability to β-lactamase . Cefuroxime sodium has a broad spectrum activity against Gram-positive and Gram-negative bacteria [1] .
Cefuroxime sodium is highly active against
S. aureus
(MIC=0.25 μg/ml), regardless of whether the strains produces a penicillinase. It is against
Staphylococcus aureus
methicillin susceptible;
S. aureus
, methicillin resistant,
Streptococcus pyogenes
,
S. pneumoniae
,
S. viridans
,
S. faecalis
, and
Clostridium spp
with MIC values of 0.25 μg/ml, 5.9 μg/ml, 0.125 μg/ml, 0.125 μg/ml, 0.125 μg/ml, >125.0 μg/ml, and 1.2 μg/ml, respectively
[1]
.
Cefuroxime sodium (10-100 μg/ml; 2-6 hours) rapidly bactericidal, its action is comparatively slow against the strains of
S. aureus
, but, even so, over 99% of the initial inoculum is killed by 6 h. The gram-negative organisms are killed rapidly, and in most cases over 99% of the very large inocula are killed within 2 h; the β-lactamase-producing strains are killed as quickly as non-enzyme-producing strains
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Rabbits (weighing 2.0 to 2.5 kg) are challenged intravenously with
S. aureus
strain 630 (a penicillinase-producing strain), the median effective dose of Cefuroxime sodium is 3 mg/kg as a result of the protection test
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT02009098 | Odense University Hospital|Region of Southern Denmark|University of Southern Denmark|Hvidovre University Hospital|Hospital of South West Jutland |
Postoperative Infection
|
October 2014 | Phase 4 |
NCT02162134 | Benazir Bhutto Hospital, Rawalpindi |
Postoperative Ileus.
|
January 2013 | Not Applicable |
NCT03141476 | Universitätsklinikum Hamburg-Eppendorf |
Obesity; Drug
|
March 1, 2017 | Phase 4 |
NCT01138852 | Attikon Hospital |
Surgical Site Infections
|
July 2004 | Phase 4 |
NCT00355602 | University of Dundee|Tenovus Scotland |
Colitis, Ulcerative
|
July 2006 | Not Applicable |
NCT04212078 | National University of Malaysia|Santen Pharmaceutical Co., Ltd. |
Endophthalmitis Postoperative
|
July 29, 2019 | Phase 1|Phase 2 |
NCT01507974 | HaEmek Medical Center, Israel |
Pregnancy Complications
|
January 16, 2012 | Not Applicable |
NCT02169856 | Benazir Bhutto Hospital, Rawalpindi |
Postoperative Nausea and Vomiting
|
July 2013 | Not Applicable |
NCT00530400 | Centre Hospitalier Universitaire Vaudois|University Hospital, Geneva|GlaxoSmithKline |
Surgical Wound Infection
|
April 1994 | Phase 4 |
NCT01080963 | Hannover Medical School|Novartis |
Wound Infection
|
November 2008 | Phase 4 |
NCT02819570 | Western Galilee Hospital-Nahariya |
Premature Rupture of Membrane
|
November 2015 | Phase 4 |
NCT00136344 | City, University of London|The European Society of Cataract and Refractive Surgeons(ESCRS)|Santen Gmbh |
Endophthalmitis
|
September 2003 | Not Applicable |
NCT02505581 | Hospital Universitari Vall d´Hebron Research Institute |
Surgical Wound Infection
|
May 2015 | Phase 4 |
NCT04479657 | Zhong Wang|China Academy of Chinese Medical Sciences |
Upper Respiratory Tract Infection|Bacterial Infection|Chinese Medicine|Pediatric Acute Upper Respiratory Tract Infection
|
October 17, 2020 | Early Phase 1 |
NCT01372371 | Ganga Hospital |
Infection
|
June 2011 | Not Applicable |
NCT00901628 | Seoul National University Hospital |
Osteoarthritis, Knee
|
April 2008 | Phase 4 |
NCT00162604 | Hvidovre University Hospital |
Uterine Prolapse|Cystocele|Rectocele|Enterocele
|
May 2005 | Not Applicable |
NCT02445859 | University of Leeds |
Surgical Site Infection
|
August 2015 | Phase 2 |
NCT04009772 | Assiut University|Yasser Esmat Mohammed |
Emergency Cesarean Section|Infection Wound
|
July 1, 2019 | Phase 2|Phase 3 |
NCT04723472 | Shanghai East Hospital |
Helicobacter Pylori Infection
|
August 1, 2023 | Not Applicable |
NCT03716804 | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
Uncomplicated Urinary Tract Infection|Antibiotic Resistant Infection
|
June 6, 2018 | Phase 4 |
NCT01524081 | The Faculty Hospital Na Bulovce |
Acute Appendicitis|Perforated Gastroduodenal Ulcer|Small Bowel Obstruction
|
July 2008 | Phase 3 |
NCT01518192 | University Medical Centre Ljubljana|Slovenian Research Agency |
Erythema Migrans|Post-Lyme Disease Symptoms
|
June 2006 | Phase 4 |
NCT01659866 | Northwestern University |
Infection
|
August 2012 | Phase 4 |
NCT00613769 | Halmstad County Hospital |
Infection Prophylaxis in Colo Rectal Surgery
|
September 2007 | Phase 4 |
NCT04161599 | Hospital Universitari Vall d´Hebron Research Institute |
Wounds and Injuries|Surgery--Complications
|
March 1, 2022 | Phase 4 |
NCT04303390 | Saud Al Babtain Cardiac Center |
Surgical Site Infection
|
February 6, 2018 | Phase 4 |
NCT04470973 | Radboud University Medical Center |
Sepsis|Septic Shock|Infection, Bacterial|Critically Ill
|
July 15, 2020 | |
NCT05398081 | Dr. Promise Tamunoipiriala Jaja|University College Hospital, Ibadan |
Surgical Site Infection|Antibiotics Prophylaxis
|
December 1, 2021 | Phase 2 |
NCT00497341 | Hospital Clinic of Barcelona |
Infection
|
January 2008 | Phase 4 |
NCT05609240 | University of Leeds|University of Birmingham|Aneurin Bevan University Health Board |
Antibiotic Prophylaxis|Colorectal Surgery
|
January 1, 2023 | Phase 2 |
NCT03020940 | Jiangsu Famous Medical Technology Co., Ltd. |
Infectious Disease
|
January 2017 | |
NCT02850250 | Alder Hey Children´s NHS Foundation Trust |
Cardiac Event
|
July 2018 | |
NCT02072798 | Odense University Hospital|University of Copenhagen|Aase and Ejnar Danielsens Foundation|Region of Southern Denmark|University of Southern Denmark |
Surgical Wound Infection|Infection; Cesarean Section|Complications; Cesarean Section
|
February 2014 | Phase 4 |
NCT00648726 | Pfizer |
Pneumonia
|
January 2003 | Phase 3 |
NCT00730938 | Presbyterian Church East Africa Kikuyu Hospital |
Cataract|Endophthalmitis
|
February 2008 | Not Applicable |
NCT01237730 | National Cheng Kung University |
The Patients Who Receive Percutaneous Endoscopic Gastrostomy|Peristomal Wound Infection After the Operation of PEG|Prophylactic Antibiotics Before PEG
|
July 2010 | Not Applicable |
NCT05337566 | Helsinki University Central Hospital|University of Turku|Tampere University Hospital|Kuopio University Hospital|Oulu University Hospital |
Infection Post Op|Hysterectomy|Antibiotics|Prophylactic
|
September 5, 2022 | Not Applicable |
NCT05577273 | Omri Schwarztuch Gildor|Clalit Health Services |
Urologic Diseases|Urinary Tract Disease
|
August 14, 2018 | Not Applicable |
NCT05388747 | Shandong University|Tianjin Central Hospital of Gynecology Obstetrics |
Infectious Disease
|
May 16, 2022 | |
NCT04378868 | Helsinki University Central Hospital |
Appendicitis
|
May 18, 2020 | Phase 4 |
NCT03584919 | University Medical Centre Ljubljana |
Erythema Chronicum Migrans
|
June 1, 2006 | Not Applicable |
NCT02789579 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
Complication of Surgical Procedure
|
September 2016 | Early Phase 1 |
NCT00000752 | National Institute of Allergy and Infectious Diseases (NIAID)|Adams Laboratories|Glaxo Wellcome |
HIV Infections|Sinusitis
|
Phase 2 | |
NCT04616352 | Universidad Nacional de Colombia |
Urinary Tract Infections
|
December 26, 2020 |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
DMSO : ≥ 100 mg/mL ( 224.03 mM )
H 2 O : 50 mg/mL ( 112.01 mM ; Need ultrasonic)
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.2403 mL | 11.2015 mL | 22.4029 mL |
5 mM | 0.4481 mL | 2.2403 mL | 4.4806 mL |
10 mM | 0.2240 mL | 1.1201 mL | 2.2403 mL |
Add each solvent one by one: PBS
Solubility: 55 mg/mL (123.22 mM); Clear solution; Need ultrasonic
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (5.60 mM); Clear solution
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.